Consumers in the U.S. are increasingly finding it harder to trust the brands they do business with. This is why Newsweek is ...

I created Within This Party as a graduation project in 2022. The world was not much better back then, than it is today. Although perhaps on the surface, it was brighter. But there was darkness in ...

Jefferies lowered the firm’s price target on Sabra Health Care to $20 from $21 and keeps a Buy rating on the shares as part of a 2025 outlook. Within healthcare real estate investment trusts ...

On Dec. 5, Mizuho analyst Vikram Malhotra downgraded the rating for Sabra Health Care REIT from Outperform to Neutral and maintained the price target of $20. On Oct. 31, Sabra Health Care REIT ...

In a report released today, Michael Lewis from Truist Financial maintained a Buy rating on Sabra Healthcare REIT (SBRA – Research Report), with a price target of $18.00. The company’s shares ...

Fintel reports that on January 7, 2025, JMP Securities upgraded their outlook for Sabra Health Care REIT (NasdaqGS:SBRA) from Market Perform to Market Outperform. As of December 23, 2024 ...

Much of America’s hummus explosion can be traced to one company, Sabra, which was in the news last week after an outbreak of listeria in Sabra hummus prompted a major recall. Its rival Tribe has ...